Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
Analogues of a Cyclic Antimicrobial Peptide with a Flexible Linker Show Promising Activity against <em>Pseudomonas aeruginosa</em> and <em>Staphylococcus aureus</em>
oleh: Thomas T. Thomsen, Helen C. Mendel, Wafaa Al-Mansour, Alberto Oddo, Anders Løbner-Olesen, Paul R. Hansen
Format: | Article |
---|---|
Diterbitkan: | MDPI AG 2020-06-01 |
Deskripsi
The emergence of multi-drug resistant bacteria is becoming a major health concern. New strategies to combat especially Gram-negative pathogens are urgently needed. Antimicrobial peptides (AMPs) found in all multicellular organisms act as a first line of defense in immunity. In recent years, AMPs have attracted increasing attention as potential antibiotics. Naturally occurring antimicrobial cyclic lipopeptides include colistin and daptomycin, both of which contain a flexible linker. We previously reported a cyclic AMP BSI-9 cyclo(Lys-Nal-Lys-Lys-Bip-O<sub>2</sub>Oc-Nal-Lys-Asn) containing a flexible linker, with a broad spectrum of activity against bacterial strains and low hemolytic activity. In this study, improvement of the antimicrobial activity of BSI-9, against the European Committee on Antimicrobial Susceptibility Testing (EUCAST) strains of <i>S. aureus</i>, <i>E. coli</i>, <i>A. baumannii</i>, and <i>P. aeruginosa</i> was examined. This led to synthesis of eighteen peptide analogues of BSI-9, produced in four individual stages, with a different focus in each stage; cyclization point, hydrophobicity, cationic side-chain length, and combinations of the last two. Specifically the modified compound <b>11</b>, exhibited improved activity against <i>Staphylococcus aureus</i> and <i>Pseudomonas aeruginosa</i> with MIC of 4 µg/mL and 8 µg/mL, respectively, compared to the original BSI-9, which had an MIC of 16–32 µg/mL.